Found: 6
Select item for more details and to access through your institution.
Dose Intensity of Standard Adjuvant CMF with Granulocyte Colony-Stimulating Factor for Premenopausal Patients with Node-Positive Breast Cancer.
- Published in:
- Oncology, 1996, v. 53, n. 4, p. 289, doi. 10.1159/000227575
- By:
- Publication type:
- Article
Relationship between Soluble Transferrin Receptors in Serum and Membrane-Bound Transferrin Receptors.
- Published in:
- Acta Haematologica, 1998, v. 99, n. 1, p. 8, doi. 10.1159/000040707
- By:
- Publication type:
- Article
Prognostic Parameters for Response to Enzalutamide After Docetaxel and Abiraterone Treatment in Metastatic Castration-Resistant Prostate Cancer Patients; a Possible Time Relation.
- Published in:
- Prostate, 2016, v. 76, n. 1, p. 32, doi. 10.1002/pros.23094
- By:
- Publication type:
- Article
Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Oncology, 2016, v. 91, n. 5, p. 267, doi. 10.1159/000448219
- By:
- Publication type:
- Article
A prospective observational registry evaluating clinical outcomes of Radium‐223 treatment in a nonstudy population.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 4, p. 1143, doi. 10.1002/ijc.32851
- By:
- Publication type:
- Article
CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxel.
- Published in:
- International Journal of Cancer, 2015, v. 136, n. 6, p. E760, doi. 10.1002/ijc.29231
- By:
- Publication type:
- Article